ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Total Current Assets
ADC Therapeutics SA
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Total Current Assets
$336.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Total Current Assets
CHf125.2m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Total Current Assets
$1.9B
|
CAGR 3-Years
4%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Total Current Assets
CHf152.1m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
Idorsia Ltd
SIX:IDIA
|
Total Current Assets
CHf596.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Total Current Assets
CHf27.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Total Current Assets?
Total Current Assets
336.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Total Current Assets amounts to 336.3m USD.
What is ADC Therapeutics SA's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
19%
Over the last year, the Total Current Assets growth was -25%. The average annual Total Current Assets growth rates for ADC Therapeutics SA have been -9% over the past three years , 19% over the past five years .